Non–Laboratory-Based Self-Assessment Screening Score for Non-Alcoholic Fatty Liver Disease: Development, Validation and Comparison with Other Scores-Reference-Cited by-同舟云学术

Non–Laboratory-Based Self-Assessment Screening Score for Non-Alcoholic Fatty Liver Disease: Development, Validation and Comparison with Other Scores

Published:2014-09-12 Issue:9 Volume:9 Page:e107584
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Lee Yong-ho,Bang Heejung,Park Young Min,Bae Ji Cheol,Lee Byung-Wan,Kang Eun Seok,Cha Bong Soo,Lee Hyun Chul,Balkau Beverley,Lee Won-Young,Kim Dae Jung

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference40 articles.

1. Nonalcoholic fatty liver disease;P Angulo;N Engl J Med,2002

2. The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association;N Chalasani;Hepatology,2012

3. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults;G Vernon;Aliment Pharmacol Ther,2011

4. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study;CD Williams;Gastroenterology,2011

5. Rising liver death rate: food for thought;LC Claridge;Lancet,2011

Cited by 114 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of nonalcoholic fatty liver disease with new-onset atrial fibrillation stratified by age groups;Cardiovascular Diabetology;2024-09-12

2. Risk of hepatic events associated with use of sodium-glucose cotransporter-2 inhibitors versus glucagon-like peptide-1 receptor agonists, and thiazolidinediones among patients with metabolic dysfunction-associated steatotic liver disease;Gut;2024-09-06

3. Risk Assessment Tool in Predicting the Therapeutic Outcomes of Antiseizure Medication in Adults with Epilepsy;Therapeutics and Clinical Risk Management;2024-08

4. Precision Non-Alcoholic Fatty Liver Disease (NAFLD) Diagnosis: Leveraging Ensemble Machine Learning and Gender Insights for Cost-Effective Detection;Bioengineering;2024-06-12

5. Metabolic dysfunction-associated fatty liver disease increases the risk of type 2 diabetes mellitus in young Korean adults;Diabetes Research and Clinical Practice;2024-06